Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2003 · 20 citations · 39 references
Veterinary MedicineImmunologyInfectious DiseasesImmunizationTransplant ImmunologyVaccinologyAdult ImmunizationImmunization CoverageImmunization SchedulesVaccinationVaccine EffectivenessVaccine EfficacyHepatitis B Surface Antigen MonitoringHepatitis B TherapyHepatitis Virus VaccinationIntramuscular Injection TechniqueTransplantationVaccination In Transplant RecipientsVaccination Responses After TransplantVaccine-induced Antibody Responses
STUDY OBJECTIVE: To increase the response rate to hepatitis B vaccine in patients awaiting lung transplantation. DESIGN: Historically controlled, open-label study. SETTING: Lung transplant clinic at a university hospital. SUBJECTS: Twenty-seven consecutive individuals with end-stage pulmonary disease who were enrolled to accrue 15 subjects who would complete the vaccine series before transplantation; and 27 lung transplant recipients who were immunized with the conventional dose before the study and served as historical controls. INTERVENTION: Intramuscular injection of high-dose hepatitis B vaccine 40 microgram at 0, 1, and 6 months. MEASUREMENTS AND MAIN RESULTS: Hepatitis B surface antibody (anti-HBs) concentrations were measured 1-2 months after completing the high-dose series. Individuals with undetectable anti-HBs received additional vaccine to a maximum of six doses. The response rate to the series was compared with that in the control group. Seventeen individuals in the high-dose group and 14 controls met the study criterion of complete vaccine series before transplantation. The former had a much higher response rate than the latter (9 [53%] vs 1 [7%], p<0.01). Four of six patients who received additional doses of vaccine seroconverted. Two of them underwent transplantation shortly after completing the three-dose series. CONCLUSION: The high-dose hepatitis B vaccine series produced a protective immune response in lung transplant recipients; however, the response was suboptimal, and alternative immunization strategies should be studied.
39
Maternal mortality surveillance, United States, 1980-1985.
Lisa M. Koonin, H K Atrash, Roger Rochat et al. · PubMed · 1988 · 513 citations
Genetic Prediction of Nonresponse to Hepatitis B Vaccine
Chester A. Alper, Margot S. Kruskall, Deborah Marcus-Bagley et al. · New England Journal of Medicine · 1989 · 403 citations
Life Sciences, Genetics, Immunology +17